The vast majority of neuroblastoma tumors demonstrate tumor cell surface expression of the norepinephrine transporter (NET), suggesting that the use of benzylguanidine analogues, such as meta-iodobenzylguanidine (MIBG), that bind to this transporter would selectively target these neuroblastoma tumor cells [33]. The gene discussed is SLC6A2; the disease is neuroblastoma.